Medical Editor: John P. Cunha, DO, FACOEP
- blurred vision
- temporary minor burning, stinging, or irritation of your eyes
Tell your doctor is you experience serious side effects of Ocucoat including:
- eye pain
- changes in vision
- continued eye redness or irritation
The recommended dosage of Ocucoat is 1 or 2 drops once or twice daily as needed. Other drugs may interact with Ocucoat. Tell your doctor all medications you take. Before taking Ocucoat remove contact lenses. When taking Ocucoat do not drive, use machinery, or do any activity that requires clear. Talk to your doctor about taking Ocucoat if you are pregnant or breastfeeding.
Our Ocucoat (hydroxypropylmethylcellulose) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
If your doctor has directed you to use this medication, remember that he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Tell your doctor immediately if any of these unlikely but serious side effects occur: eye pain, change in vision, continued eye redness/irritation.
A very serious allergic reaction to this drug is rare. However, seek immediate medical attention if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the entire patient information overview for Ocucoat (Hydroxypropylmethylcellulose)
Clinical testing of OCUCOAT (hydroxypropylmethylcellulose) showed it to be extremely well tolerated after injection into the human eye.
A transient rise in intraocular pressure postoperatively has been reported in some cases.
Rarely, postoperative inflammatory reactions (iritis, hypopyon), as well as incidents of corneal edema and corneal decompensation, have been reported with viscoelastic agents. Their relationship to OCUCOAT (hydroxypropylmethylcellulose) has not been established.
Read the entire FDA prescribing information for Ocucoat (Hydroxypropylmethylcellulose)
© Ocucoat Patient Information is supplied by Cerner Multum, Inc. and Ocucoat Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.